Skip to main content
. 2021 Apr 19;21(10):1383–1394. doi: 10.1016/S1473-3099(21)00200-0

Figure 1.

Figure 1

Trial profile

*Includes one sentinel participant whose immediate post-dose safety data were reviewed by the safety review committee before proceeding with dosing of the rest of the cohort. † Cumulative safety data from the first 7 days after the first dose of each cohort were reviewed by the safety review committee before proceeding to the next higher-dose cohort.